130 related articles for article (PubMed ID: 9489928)
1. The D3 dopamine receptor in cellular and organismal function.
Shafer RA; Levant B
Psychopharmacology (Berl); 1998 Jan; 135(1):1-16. PubMed ID: 9489928
[TBL] [Abstract][Full Text] [Related]
2. The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.
Heidbreder CA; Gardner EL; Xi ZX; Thanos PK; Mugnaini M; Hagan JJ; Ashby CR
Brain Res Brain Res Rev; 2005 Jul; 49(1):77-105. PubMed ID: 15960988
[TBL] [Abstract][Full Text] [Related]
3. Bitropic D3 Dopamine Receptor Selective Compounds as Potential Antipsychotics.
Luedtke RR; Rangel-Barajas C; Malik M; Reichert DE; Mach RH
Curr Pharm Des; 2015; 21(26):3700-24. PubMed ID: 26205291
[TBL] [Abstract][Full Text] [Related]
4. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
[TBL] [Abstract][Full Text] [Related]
5. D3 dopamine receptor, behavioral sensitization, and psychosis.
Richtand NM; Woods SC; Berger SP; Strakowski SM
Neurosci Biobehav Rev; 2001 Jul; 25(5):427-43. PubMed ID: 11566480
[TBL] [Abstract][Full Text] [Related]
6. The D3 dopamine receptor and substance dependence.
Richtand NM; Goldsmith RJ; Nolan JE; Berger SP
J Addict Dis; 2001; 20(3):19-32. PubMed ID: 11681590
[TBL] [Abstract][Full Text] [Related]
7. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
Gyertyán I; Gál K
Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838
[TBL] [Abstract][Full Text] [Related]
9. [Functional role of dopamine D3 receptor in schizophrenia].
Semba J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs.
Joyce JN
Pharmacol Ther; 2001; 90(2-3):231-59. PubMed ID: 11578658
[TBL] [Abstract][Full Text] [Related]
11. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter.
McGinnis MM; Siciliano CA; Jones SR
J Neurochem; 2016 Sep; 138(6):821-9. PubMed ID: 27393374
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a functional role of the dopamine D3 receptors in the cerebellum.
Barik S; de Beaurepaire R
Brain Res; 1996 Oct; 737(1-2):347-50. PubMed ID: 8930390
[TBL] [Abstract][Full Text] [Related]
14. Role of dopamine D3 receptors in the addictive properties of ethanol.
Heidbreder CA; Andreoli M; Marcon C; Thanos PK; Ashby CR; Gardner EL
Drugs Today (Barc); 2004 Apr; 40(4):355-65. PubMed ID: 15190388
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion.
Pritchard LM; Newman AH; McNamara RK; Logue AD; Taylor B; Welge JA; Xu M; Zhang J; Richtand NM
Pharmacol Biochem Behav; 2007 Apr; 86(4):718-26. PubMed ID: 17408730
[TBL] [Abstract][Full Text] [Related]
16. The dopamine D3 receptor, a quarter century later.
Sokoloff P; Le Foll B
Eur J Neurosci; 2017 Jan; 45(1):2-19. PubMed ID: 27600596
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
[TBL] [Abstract][Full Text] [Related]
18. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.
Gál K; Gyertyán I
Drug Alcohol Depend; 2006 Jan; 81(1):63-70. PubMed ID: 16005579
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra.
Newman-Tancredi A; Cussac D; Brocco M; Rivet JM; Chaput C; Touzard M; Pasteau V; Millan MJ
Brain Res; 2001 Nov; 920(1-2):41-54. PubMed ID: 11716810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]